Close Menu

NEW YORK (GenomeWeb) – Premaitha Health said today that it plans to raise approximately £2.5 million ($3.3 million) through a fast offering of ordinary shares, a so-called accelerated bookbuild, that will proceed in two tranches. It is offering the shares at a price of 10 pence per ordinary share, which represents a discount of 19 percent to the closing price on September 27.

The first tranche of shares will be allotted on Oct. 4 and the second tranche on Oct. 25.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.